Cargando…
Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions
Since the discovery of the potential role for the gut microbiota in health and disease, many studies have gone on to report its impact in various pathologies. These studies have fuelled interest in the microbiome as a potential new target for treating disease Here, we reviewed the key metabolic dise...
Autores principales: | Proffitt, Ceri, Bidkhori, Gholamreza, Moyes, David, Shoaie, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565856/ https://www.ncbi.nlm.nih.gov/pubmed/32916966 http://dx.doi.org/10.3390/microorganisms8091381 |
Ejemplares similares
-
Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
por: Proffitt, Ceri, et al.
Publicado: (2022) -
Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
por: Rosario, Dorines, et al.
Publicado: (2018) -
Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment
por: Ezzamouri, Bouchra, et al.
Publicado: (2023) -
Systematic diet composition swap in a mouse genome-scale metabolic model reveals determinants of obesogenic diet metabolism in liver cancer
por: Clasen, Frederick, et al.
Publicado: (2023) -
Host-mycobiome metabolic interactions in health and disease
por: Begum, Neelu, et al.
Publicado: (2022)